Join to View Full Profile
1190 5th AveNew York, NY 10029
Phone+1 212-241-6756
Fax+1 212-423-0522
Dr. Brody is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2004 - 2007
Yale-New Haven Medical CenterResidency, Internal Medicine, 2000 - 2003
Stony Brook University Health Sciences Center School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2003 - Present
NY State Medical License 2012 - 2025
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymphoma Start of enrollment: 2011 Feb 01
- A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers Start of enrollment: 2011 Oct 01
- In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy Start of enrollment: 2014 Jan 03
- Join now to see all
Publications & Presentations
PubMed
- Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for gl...Lorenzo Falchi, Martin Hutchings, Carmelo Carlo-Stella, Franck Morschhauser, Michael Dickinson
Haematologica. 2025-04-01 - 1 citationsA patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities.Danilo Fiore, Luca Vincenzo Cappelli, Liu Zhaoqi, Nikita Kotlov, Maria Sorokina
Cell Reports. Medicine. 2025-03-24 - Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation.Zachary S Morris, Sandra Demaria, Arta M Monjazeb, Silvia C Formenti, Ralph R Weichselbaum
The Lancet. Oncology. 2025-03-01
Press Mentions
Chemotherapy and Immunotherapy Combo Shows Promise for Aggressive LymphomaJanuary 23rd, 2025- High-Dose Chemo, ASCT Improves Survival in Primary CNS LymphomaDecember 14th, 2022
- Novel Vaccine Approach Halts Disease After 23 Years of Breast CancerDecember 10th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
